Vimarsana
Biggest News Aggregation in the World

Page 3 - Device Manufacturing News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Device Manufacturing. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Device Manufacturing Today - Breaking & Trending Today

Digital Health Market Size Worth USD 1,518.64 Billion in 2030 - Vimarsana News

Digital Health Market Size Worth USD 1,518.64 Billion in 2030

/PRNewswire/ -- According to the latest analysis by Emergen Research, the global digital health market size was valued at USD 175.20 Billion in 2021 and is...

Companion Animal Diagnostics Market Size to Reach USD 5.12 Billion in 2030 - Vimarsana News

Companion Animal Diagnostics Market Size to Reach USD 5.12 Billion in 2030

/PRNewswire/ -- The companion animal diagnostics market size reached USD 2.23 Billion in 2021 and is expected to register a CAGR of 9.7% during the forecast...

Companion Animal Diagnostics Market Size to Reach USD 5.12 Billion in 2030 | Emergen Research - Vimarsana News

Companion Animal Diagnostics Market Size to Reach USD 5.12 Billion in 2030 | Emergen Research

VANCOUVER, BC, Feb. 20, 2023 /PRNewswire/ -- The companion animal diagnostics market size reached USD 2.23 Billion in 2021 and is expected to register a CAGR of

MediBeacon Receives $10 Million in Amended Agreements with Huadong Medicine to Accelerate Development of Transdermal GFR Measurement System - Vimarsana News

MediBeacon Receives $10 Million in Amended Agreements with Huadong Medicine to Accelerate Development of Transdermal GFR Measurement System

/PRNewswire/ -- MediBeacon Inc., a portfolio company within the Pansend Life Sciences segment of INNOVATE Corp. (NYSE: VATE), today announced amendments to its...

MediBeacon Inc.: MediBeacon Receives $10 Million in Amended Agreements with Huadong Medicine to Accelerate Development of Transdermal GFR Measurement System - Vimarsana News

MediBeacon Inc.: MediBeacon Receives $10 Million in Amended Agreements with Huadong Medicine to Accelerate Development of Transdermal GFR Measurement System

MediBeacon approaching completion of Phase 3 study focused on kidney disease; Has submitted three of five required PMA modules needed for FDA approval ST. LOUIS, Nov. 16, 2022 /PRNewswire/